RODHAM might be one of the last to have shares to dillute. also does anyone know when we get the other 6mill from RODHAM, remember it was a 12mill deal. do we get the other 6mill after the R/S. if we do that would not make sense. why not just strike a deal for 6mill then.
Hey Ryan, I know some people where saying Synta was a possibility but I just put that to rest. I just got off the phone with a Vice president and he said the people at Genta couldnt follow basic clinical trial rules and when the FDA is well aware of it. He said the FDA has simple mathmaticle equations to determine overall survival and in most of the Genasense trials Genta didnt follow instructions and the FDA said they could have fudged some of the number or not but they didnt follow the rules so there was no way to be sure. Thats why they have to keep doing everything over and over and over. What a bunch of idiots!!!!!!
Market Data 
Markets 
AI
